Paragon 28 Inc Revenue per Employee (FNA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Paragon 28 inc   (NYSE: FNA)
 

Paragon 28 Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 20.53% in the fourth quarter 2024, year on year to cumulative value of $255 million, Paragon 28 Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,774,229, this marks a new company high.
Within the Healthcare sector Employees of 41 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 428, from total ranking in previous quarter at 450. Paragon 28 Inc has 144 employees.


What is Sales per Employee Ratio?







FNA Revenue per Employee (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Revenue Change 20.53 % 18.68 % 19.11 % 15.77 % 16.49 %
Sales per Employee (TTM) $ 1,774,229 1,688,701 1,620,729 1,553,049 1,496,076
FNA's Total Ranking # 428 # 450 # 516 # 0 # 0
Seq. Revenue Change 16.31 % 2.34 % 0.85 % 0.4 % 14.53 %


Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 3
Healthcare Sector # 42
Overall Market # 428

Revenue per Employee Statistics
High Average Low
$ 1,774,229 $ 1,253,355 $ 248,965
(Dec 31 2024)   (Sep 30 2021)



Financial Statements
Paragon 28 Inc 's Revenue MRQ $ 72 Millions Visit FNA's Income Statement
Paragon 28 Inc 's Revenues TTM $ 255 Millions Visit FNA's aggregate revenue growth
What are FNA's Sales? Visit FNA's Sales by Segment




Other Ratios
Paragon 28 Inc 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
FNA's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for FNA's Competitors
Revenue per Employee for FNA's Suppliers
Revenue per Employee for FNA's Customers

You may also want to know
FNA's Sales Growth Rates FNA's Pe Price to earnings ratio FNA's Receivables Turnover Ratio FNA's Stock Quote
FNA's Net Income Growth Rates FNA's Ps Price to Sales ratio FNA's Sales per Employee FNA's Asset Turnover Ratio
FNA's Net Margin FNA's Pb Price to Book ratio FNA's Financial Strength Ratios FNA's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:27+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2024Number of Employees Dec 31 2024
Equillium Inc   2,935,357.14 $ 41.095  Million 14 
Siga Technologies Inc  2,831,007.14 $ 138.719  Million 49 
Catalyst Pharmaceuticals Inc   2,701,835.16 $ 491.734  Million 182 
Innoviva Inc   2,628,125.79 $ 417.872  Million 159 
Amgen Inc   2,571,076.92 $ 33,424.000  Million 13,000 
Grifols Sa  2,514,120.09 $ 8,077.868  Million 3,213 
Harmony Biosciences Holdings inc   2,436,583.62 $ 713.919  Million 293 
Halozyme Therapeutics Inc   2,400,293.14 $ 1,015.324  Million 423 
Assertio Holdings inc   2,357,754.72 $ 124.961  Million 53 
Sarepta Therapeutics Inc   2,277,819.16 $ 1,901.979  Million 835 
Indivior Pharmaceuticals Inc   2,078,000.00 $ 2,078.000  Million 1,000 
United Therapeutics Corporation  2,055,285.71 $ 2,877.400  Million 1,400 
Xoma Royalty Corporation  2,034,785.71 $ 28.487  Million 14 
Prothena Corporation Public Limited Company  2,017,268.66 $ 135.157  Million 67 
Cytomx Therapeutics Inc   2,001,492.75 $ 138.103  Million 69 
Prestige Consumer Healthcare Inc   1,961,877.19 $ 1,118.270  Million 570 
Spero Therapeutics Inc   1,919,080.00 $ 47.977  Million 25 
Exelixis Inc   1,890,759.37 $ 2,168.701  Million 1,147 
Ascendis Pharma A  1,870,714.27 $ 187.071  Million 100 
Aurinia Pharmaceuticals Inc   1,836,976.56 $ 235.133  Million 128 
Coherus Oncology inc   1,816,054.42 $ 266.960  Million 147 
Semler Scientific inc   1,815,935.48 $ 56.294  Million 31 
Paragon 28 inc   1,774,229.17 $ 255.489  Million 144 
Petros Pharmaceuticals inc   1,729,261.00 $ 5.188  Million
Gilead Sciences Inc   1,691,411.76 $ 28,754.000  Million 17,000 
Therapeuticsmd Inc   1,682,000.00 $ 1.682  Million
Scilex Holding Company  1,664,411.76 $ 56.590  Million 34 
Curevac N v   1,620,004.32 $ 599.402  Million 370 
Hookipa Pharma inc   1,569,500.00 $ 43.946  Million 28 
Nektar Therapeutics  1,562,333.33 $ 98.427  Million 63 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.